Therapeutic area
Background info
Intellectual property

What the technology does

REXER: Incorporation of large (up to 100mb) of synthetic DNA into the E. coli chromosome.


Efficient and single step in vivo insertion or replacement of more than 100 kb synthetic DNA into the E. coli chromosome, including replacement of entire operon and genome. 100% integration at target locus.

Main application field

Genome engineering of E. coli


Research Tool


Technology ready for evaluation.

Intellectual Property

Patent application filed in July 2016


Exclusive or non-exclusive licence

Key Contact

  • Hidden
  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
All Licensing Opportunities